Amended Statement of Ownership (sc 13g/a)
July 10 2018 - 4:05PM
Edgar (US Regulatory)
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
SCHEDULE 13G
(Amendment No.
2)
Under the Securities
Exchange Act of 1934
Ophthotech Corporation
(Name of Issuer)
Common Stock,
$0.001 par value
(Title of Class of
Securities)
683745103
(CUSIP Number)
June 30, 2018
(Date of Event Which
Requires Filing of this Statement)
Check the following box to designate the rule pursuant to which
the Schedule is filed:
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act")
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
CUSIP No. 683745103
|
|
1.
|
Names of Reporting Persons
I.R.S. Identification Nos. of above persons (entities
only)
D. E. Shaw & Co., L.L.C.
13-3799946
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
(a)
|
[ ]
|
|
|
(b)
|
[ ]
|
|
3.
|
SEC Use Only
|
|
4.
|
Citizenship or Place of Organization
Delaware
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5.
|
Sole Voting Power
-0-
|
|
|
|
6.
|
Shared Voting Power
2,031,132
|
|
|
|
7.
|
Sole Dispositive Power
-0-
|
|
|
|
8.
|
Shared Dispositive Power
2,031,132
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting
Person
2,031,132
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions) [ ]
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
5.6%
|
|
12.
|
Type of Reporting Person (See Instructions)
OO
|
CUSIP No. 683745103
|
|
1.
|
Names of Reporting Persons
I.R.S. Identification Nos. of above persons (entities
only)
D. E. Shaw & Co., L.P.
13-3695715
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
(a)
|
[ ]
|
|
|
(b)
|
[ ]
|
|
3.
|
SEC Use Only
|
|
4.
|
Citizenship or Place of Organization
Delaware
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5.
|
Sole Voting Power
-0-
|
|
|
|
6.
|
Shared Voting Power
2,630,813
|
|
|
|
7.
|
Sole Dispositive Power
-0-
|
|
|
|
8.
|
Shared Dispositive Power
2,713,593
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting
Person
2,713,593
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions) [ ]
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
7.5%
|
|
12.
|
Type of Reporting Person (See Instructions)
IA, PN
|
CUSIP No. 683745103
|
|
1.
|
Names of Reporting Persons
I.R.S. Identification Nos. of above persons (entities
only)
David E. Shaw
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
(a)
|
[ ]
|
|
|
(b)
|
[ ]
|
|
3.
|
SEC Use Only
|
|
4.
|
Citizenship or Place of Organization
United States
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5.
|
Sole Voting Power
-0-
|
|
|
|
6.
|
Shared Voting Power
2,630,813
|
|
|
|
7.
|
Sole Dispositive Power
-0-
|
|
|
|
8.
|
Shared Dispositive Power
2,713,593
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting
Person
2,713,593
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions) [ ]
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
7.5%
|
|
12.
|
Type of Reporting Person (See Instructions)
IN
|
Item 1.
|
|
(a)
|
Name of Issuer
|
|
|
Ophthotech Corporation
|
|
(b)
|
Address of Issuer's Principal Executive Offices
|
|
|
One Penn Plaza, 35th Floor
New York, NY 10119
|
|
|
Item 2.
|
|
(a)
|
Name of Person Filing
|
|
|
D. E. Shaw & Co., L.L.C.
D. E. Shaw & Co., L.P.
David E. Shaw
|
|
|
|
(b)
|
Address of Principal Business Office or, if none, Residence
|
|
|
The business address for each reporting person is:
1166 Avenue of the Americas, 9
th
Floor
New York, NY 10036
|
|
(c)
|
Citizenship
|
|
|
D. E. Shaw & Co., L.L.C. is a limited
liability company organized under the laws of the state of Delaware.
D. E. Shaw & Co., L.P. is a limited partnership organized under the laws of the state of Delaware.
David E. Shaw is a citizen of the United States of
America.
|
|
(d)
|
Title of Class of Securities
|
|
|
Common Stock, $0.001 par value
|
|
(e)
|
CUSIP Number
|
|
|
683745103
|
Item 3.
|
If this statement is filed pursuant to Rule 13d-1(b)
or 13d-2(b) or (c), check whether the person filing is a:
|
Not Applicable
|
Item 4.
|
Ownership
|
As of June 30, 2018:
|
(a)
|
Amount beneficially
owned:
|
|
|
|
|
D. E. Shaw & Co., L.L.C.:
|
2,031,132 shares
This is composed of (i) 1,124,369 shares in the name
of D. E. Shaw Valence Portfolios, L.L.C. and (ii) 906,763 shares in the name of D. E. Shaw Oculus
Portfolios, L.L.C.
|
|
D. E. Shaw & Co., L.P.:
|
2,713,593 shares
This is composed of (i) 1,124,369 shares in the name
of D. E. Shaw Valence Portfolios, L.L.C., (ii) 906,763 shares in the name of D. E. Shaw Oculus Portfolios,
L.L.C., and (iii) 682,461 shares under the management of D. E. Shaw Investment Management, L.L.C.
|
|
David E. Shaw:
|
2,713,593 shares
This is composed of (i) 1,124,369 shares in the name
of D. E. Shaw Valence Portfolios, L.L.C., (ii) 906,763 shares in the name of D. E. Shaw Oculus Portfolios,
L.L.C., and (iii) 682,461 shares under the management of D. E. Shaw Investment Management, L.L.C.
|
|
D. E. Shaw & Co., L.L.C.:
|
5.6%
|
|
D. E. Shaw & Co., L.P.:
|
7.5%
|
|
David E. Shaw:
|
7.5%
|
|
(c)
|
Number of shares
to which the person has:
|
|
(i)
|
Sole power
to vote or to direct the vote:
|
|
D. E. Shaw & Co., L.L.C.:
|
-0- shares
|
|
D. E. Shaw & Co., L.P.:
|
-0- shares
|
|
David E. Shaw:
|
-0- shares
|
|
(ii)
|
Shared power
to vote or to direct the vote:
|
|
D. E. Shaw & Co., L.L.C.:
|
2,031,132 shares
|
|
D. E. Shaw & Co., L.P.:
|
2,630,813 shares
|
|
David E. Shaw:
|
2,630,813 shares
|
|
(iii)
|
Sole power
to dispose or to direct the disposition of:
|
|
D. E. Shaw & Co., L.L.C.:
|
-0- shares
|
|
D. E. Shaw & Co., L.P.:
|
-0- shares
|
|
David E. Shaw:
|
-0- shares
|
|
(iv)
|
Shared power
to dispose or to direct the disposition of:
|
|
D. E. Shaw & Co., L.L.C.:
|
2,031,132 shares
|
|
D. E. Shaw & Co., L.P.:
|
2,713,593 shares
|
|
David E. Shaw:
|
2,713,593 shares
|
David E. Shaw does not own any shares directly. By virtue of
David E. Shaw’s position as President and sole shareholder of D. E. Shaw & Co., Inc., which is the general
partner of D. E. Shaw & Co., L.P., which in turn is the investment adviser of D. E. Shaw Valence Portfolios,
L.L.C. and D. E. Shaw Oculus Portfolios, L.L.C. and the managing member of D. E. Shaw Investment Management,
L.L.C., and by virtue of David E. Shaw’s position as President and sole shareholder of D. E. Shaw & Co. II,
Inc., which is the managing member of D. E. Shaw & Co., L.L.C., which in turn is the manager of D. E. Shaw
Valence Portfolios, L.L.C. and D. E. Shaw Oculus Portfolios, L.L.C., David E. Shaw may be deemed to have the shared
power to vote or direct the vote of 2,630,813 shares, and the shared power to dispose or direct the disposition of 2,713,593 shares,
the 2,713,593 shares as described above constituting 7.5% of the outstanding shares and, therefore, David E. Shaw may be deemed
to be the beneficial owner of such shares. David E. Shaw disclaims beneficial ownership of such 2,713,593 shares.
Item 5.
|
Ownership of Five Percent or Less of a Class
|
Not Applicable
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
Not Applicable
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being
Reported on By the Parent Holding Company or Control Person.
|
Not Applicable
|
Item 8.
|
Identification and Classification of Members of the Group
|
Not Applicable
|
Item 9.
|
Notice of Dissolution of Group
|
Not Applicable
|
Item 10.
|
Certification
|
By signing below, each of D. E. Shaw & Co., L.L.C.,
D. E. Shaw & Co., L.P., and David E. Shaw certify that, to the best of such reporting person’s knowledge and
belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant
in any transaction having such purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of their knowledge
and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Powers of
Attorney, dated March 1, 2017, granted by David E. Shaw in favor of Nathan Thomas, are attached hereto.
Dated: July 10, 2018
|
D. E. Shaw & Co., L.L.C.
|
|
|
|
By:
|
/s/ Nathan Thomas
|
|
|
Nathan Thomas
|
|
|
Authorized Signatory
|
|
|
|
|
D. E. Shaw & Co., L.P.
|
|
|
|
By:
|
/s/ Nathan Thomas
|
|
|
Nathan Thomas
|
|
|
Chief Compliance Officer
|
|
|
|
|
David E. Shaw
|
|
|
|
By:
|
/s/ Nathan Thomas
|
|
|
Nathan Thomas
|
|
|
Attorney-in-Fact for David E. Shaw
|
OPHTHOTECH CORP. (NASDAQ:OPHT)
Historical Stock Chart
From Apr 2024 to May 2024
OPHTHOTECH CORP. (NASDAQ:OPHT)
Historical Stock Chart
From May 2023 to May 2024